Diabetes technology does not prevent all cases of severe hypoglycaemia, research suggests

A high proportion of people with type 1 diabetes do not achieve glycaemic targets and continue to experience severe hypoglycaemic events, despite the rise of advanced diabetes technologies. 

New research has also found that the use of diabetes technologies does not prevent impaired awareness of hypoglycaemia in people with type 1 diabetes.

A total of 2,074 adults with type 1 diabetes from the T1D Exchange Registry / online community took part in the observational study.

Each participant completed a one-time online survey to outline their glycaemic metrics, how often they experience severe hypoglycaemic events and how aware they are of hypoglycaemia.

The researchers also performed additional subgroup analyses focusing on the impact of CGM and insulin delivery modality.

More than 91% of the participants were using CGM, with one half incorporating automated insulin delivery.

Despite high use of diabetes technologies, only 57.7% reported achieving glycaemic targets. Severe hypoglycaemic events and impaired awareness of hypoglycaemia still occurred, regardless of CGM or automated insulin delivery use.

To read the study, click here.